Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 4Nasopharyngeal Carcinoma 3Esophageal Neoplasms 3Colorectal Neoplasms 3Barrett Esophagus 2Urogenital Neoplasms 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Locally Advanced Pancreatic Cancer 1Jaw Cysts 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Colitis 1Carcinoma, Non-Small-Cell Lung 1Bacteremia 1

Interventions

Fecal Microbiota Transplantation 3vedolizumab 1prednylidene 1deltacortene 1Standard of Care 1Prednisone 1Practice Guidelines as Topic 1Loperamide 1LDP-02 1Infliximab 1Immunoglobulin G 1Endoscopy 1Disulfides 1CT-P13 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colitis × Endoscopy × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡